Top compounds associated with response to CLDN34


Feature Type Standardized
Nominal ANOVA
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.25 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA Crizotinib gCSI pan-cancer AAC -0.13 0.03
mRNA paclitaxel gCSI pan-cancer AAC -0.12 0.03
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.03
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC 0.098 0.03
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.093 0.04
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.079 0.04
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.064 0.04
mRNA austocystin d CTRPv2 pan-cancer AAC 0.076 0.05
Download CSV